ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999

DCBD Board Approves Concepts For 43.5 Million In New Grants, $1.9 Million In Contract Supported Projects

November 13, 1981